Transurethral resection of the prostate revisited and updated
- 1 January 2011
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Urology
- Vol. 21 (1), 36-41
- https://doi.org/10.1097/mou.0b013e3283411455
Abstract
Electrosurgical transurethral resection (TUR) of the prostate (TURP) has dominated symptomatic benign prostatic hyperplasia (s-BPH) surgical treatment for almost a century. We analysed recent TURP publications, with emphasis on durability, morbidity, new technology advantages, future generation training and malignant disease. TURP has declined due to medical therapy, but transcends other surgical challengers by proven outcomes durability over a decade. Adopting the modified-Clavien system may aid future morbidity comparisons. Properly used bipolar technology reduces major bleeding and seemingly abolishes TUR syndrome, but requires further study in anticoagulated patients. Residents are disturbingly short of TURP exposure, consequently experiencing more complications. Solutions include switching to ablative laser prostatectomy (which may carry higher long-term retreatment rates), adoption of bipolar technology, or simulator development and implementation. Concurrently performed transurethral resection of bladder tumor-TURP seems oncologically acceptable (in selected cases); incidentally detected significant prostate cancer at TURP may have declined, whereas TURP for prostate cancer may indicate the need for earlier androgen deprivation. TURP is still rightly the dominant, most widely performed, versatile and cost-effective surgical treatment for s-BPH, reducing morbidity further with technical and technological developments. A better evidence base is required for newer technologies through large well designed multicentre-multinational randomized controlled trials incorporating standardized morbidity and long-term outcomes reporting.Keywords
This publication has 23 references indexed in Scilit:
- A randomized comparison between three types of irrigating fluids during transurethral resection in benign prostatic hyperplasiaBMC Anesthesiology, 2010
- Bipolar transurethral resection of the prostate causes less bleeding than the monopolar technique: a single‐centre randomized trial of 202 patientsBJU International, 2010
- The 12‐year symptomatic outcome of transurethral resection of the prostate for patients with lower urinary tract symptoms suggestive of benign prostatic obstruction compared to the urodynamic findings before surgeryBJU International, 2010
- Comparison of the thermal and histopathological effects of bipolar and monopolar electrosurgical resection of the prostate in a canine modelBJU International, 2010
- The Diminishing Role of Transurethral Resection of the ProstateAnnals of Surgical Oncology, 2010
- Transurethral Resection of the Prostate Syndrome: Almost Gone but Not ForgottenJournal of Endourology, 2009
- Development and External Validation of a Highly Accurate Nomogram for the Prediction of Perioperative Mortality After Transurethral Resection of the Prostate for Benign Prostatic HyperplasiaJournal of Urology, 2009
- IS CLAVIEN THE NEW STANDARD FOR REPORTING UROLOGICAL COMPLICATIONS?BJU International, 2009
- Surgical treatments for men with benign prostatic enlargement: cost effectiveness studyBMJ, 2009
- Properties in Penetrating Capsula of Transurethral Plasmakinetic Resection: Comparison with Transurethral Resection of the Prostate in an ex vivo StudyUrologia Internationalis, 2009